Johnson & Johnson Pre-Tax Income 2012-2026 | JNJ

Johnson & Johnson pre-tax income for the twelve months ending March 31, 2026 was $24.940B, a 6.25% decline year-over-year.

  • Johnson & Johnson annual pre-tax income for 2025 was $32.581B, a 95.25% increase from 2024.
  • Johnson & Johnson annual pre-tax income for 2024 was $16.687B, a 10.79% increase from 2023.
  • Johnson & Johnson annual pre-tax income for 2023 was $15.062B, a 22.2% decline from 2022.

Johnson & Johnson Pre-Tax Income 2012-2026 | JNJ

  • Johnson & Johnson annual pre-tax income for 2025 was $32.581B, a 95.25% increase from 2024.
  • Johnson & Johnson annual pre-tax income for 2024 was $16.687B, a 10.79% increase from 2023.
  • Johnson & Johnson annual pre-tax income for 2023 was $15.062B, a 22.2% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B